CRI Impact Grant

The CRI Impact Grant funds translational immunology research focused on advancing effective immunotherapies for chordoma. Grants support projects that bridge basic immunological discovery and clinical application, including therapeutic development, biomarker discovery, and models to improve immunotherapy testing. Awards provide multi-year research funding to investigators with a clear line of sight to patient benefit. Research supported by the award may be conducted at eligible medical schools and research centers in the United States or abroad.

$300,000 over 2 years in research funding; up to 10% indirect costs to the institution.

Candidates must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award activation; if not, institutional documentation must confirm the applicant will hold such a position by award activation. CRI has no citizenship restrictions. CRI Impact Grants do not support research at for-profit institutions.

Two-stage process: submit a Letter of Intent by the LOI deadline; invited applicants submit a full proposal. LOIs are submitted electronically via the CRI application portal; required uploads include an initial research concept (max 3 pages), brief description of current research, CV, and bibliography (past 5 years or relevant publications).